Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

810 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Systematic identification of cancer-specific MHC-binding peptides with RAVEN.
Baldauf MC, Gerke JS, Kirschner A, Blaeschke F, Effenberger M, Schober K, Rubio RA, Kanaseki T, Kiran MM, Dallmayer M, Musa J, Akpolat N, Akatli AN, Rosman FC, Özen Ö, Sugita S, Hasegawa T, Sugimura H, Baumhoer D, Knott MML, Sannino G, Marchetto A, Li J, Busch DH, Feuchtinger T, Ohmura S, Orth MF, Thiel U, Kirchner T, Grünewald TGP. Baldauf MC, et al. Among authors: sugimura h. Oncoimmunology. 2018 Jul 23;7(9):e1481558. doi: 10.1080/2162402X.2018.1481558. eCollection 2018. Oncoimmunology. 2018. PMID: 30228952 Free PMC article.
YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non-small-cell lung cancer.
Tsuchiya K, Yoshimura K, Inoue Y, Iwashita Y, Yamada H, Kawase A, Watanabe T, Tanahashi M, Ogawa H, Funai K, Shinmura K, Suda T, Sugimura H. Tsuchiya K, et al. Among authors: sugimura h. Oncoimmunology. 2021 Aug 10;10(1):1962656. doi: 10.1080/2162402X.2021.1962656. eCollection 2021. Oncoimmunology. 2021. PMID: 34408926 Free PMC article.
CD200 and CD200R1 are differentially expressed and have differential prognostic roles in non-small cell lung cancer.
Yoshimura K, Suzuki Y, Inoue Y, Tsuchiya K, Karayama M, Iwashita Y, Kahyo T, Kawase A, Tanahashi M, Ogawa H, Inui N, Funai K, Shinmura K, Niwa H, Sugimura H, Suda T. Yoshimura K, et al. Among authors: sugimura h. Oncoimmunology. 2020 Apr 7;9(1):1746554. doi: 10.1080/2162402X.2020.1746554. eCollection 2020. Oncoimmunology. 2020. PMID: 32395395 Free PMC article.
Identification and association study with lung cancer for novel insertion polymorphisms of human endogenous retrovirus.
Kahyo T, Tao H, Shinmura K, Yamada H, Mori H, Funai K, Kurabe N, Suzuki M, Tanahashi M, Niwa H, Ogawa H, Tanioka F, Yin G, Morita M, Matsuo K, Kono S, Sugimura H. Kahyo T, et al. Among authors: sugimura h. Carcinogenesis. 2013 Nov;34(11):2531-8. doi: 10.1093/carcin/bgt253. Epub 2013 Jul 19. Carcinogenesis. 2013. PMID: 23872666 Clinical Trial.
Expression profile of EFNB1, EFNB2, two ligands of EPHB2 in human gastric cancer.
Kataoka H, Tanaka M, Kanamori M, Yoshii S, Ihara M, Wang YJ, Song JP, Li ZY, Arai H, Otsuki Y, Kobayashi T, Konno H, Hanai H, Sugimura H. Kataoka H, et al. Among authors: sugimura h. J Cancer Res Clin Oncol. 2002 Jul;128(7):343-8. doi: 10.1007/s00432-002-0355-0. Epub 2002 Jun 26. J Cancer Res Clin Oncol. 2002. PMID: 12136247
810 results